Why the Radoff-JEC bid for Seer is bigger than a small-cap biotech takeover fight
Find out why Seer’s activist battle could reshape investor thinking on proteomics, diagnostics platforms and biotech value creation.
GHO Capital and CBC Group deal signals a bigger private capital push into life sciences
GHO Capital and CBC Group are creating a $21bn healthcare investor. Find out what it means for pharma, medtech and life sciences funding.
Can Europe contain its STI surge before antimicrobial resistance narrows treatment options?
Europe’s STI surge is testing diagnostics, prevention and treatment capacity as gonorrhoea and syphilis reach record levels.
SOLVD Health broadens AvertD access as FDA clears blood-based sample collection
FDA cleared blood-based collection for SOLVD Health’s AvertD. Find out why this could expand genetic opioid risk testing in surgical care.
Is Legacy’s vasectomy solution setting a new standard for post-procedure patient management?
Legacy’s new AUA-aligned vasectomy platform combines sperm banking and mail-in PVSA—find out how it could reshape male fertility care in the U.S.
FDA clears VizMark’s VM1 tumor marker: Is this the fix for MRI artifact in breast imaging?
VizMark’s VM1 marker receives FDA clearance for artifact-free breast imaging. Find out how this may change tumor localization in dense breast cases.
Can Bio-Techne and Wyss Geneva make 3D spatial biology mainstream?
Bio-Techne Corporation has announced a strategic partnership with the Wyss Center for Bio and Neuroengineering in Geneva to develop an automated platform for simultaneous RNA and protein detection in 3D tissue samples. The collaboration aims to reduce technical complexity and accelerate adoption of spatial biology tools by enabling high-resolution multiomic analysis in intact three-dimensional specimens. […]
How KVP International’s SafePath-IVD buy could reshape veterinary and human diagnostics
KVP International has announced the acquisition of SafePath Laboratories and IVD Research, a diagnostics manufacturer and contract development and manufacturing organization (CDMO) provider headquartered in Carlsbad, California. With this move, KVP International aims to strengthen its footprint in veterinary diagnostics while unlocking the potential to expand into human health markets. This acquisition provides KVP International […]